CORD-19:a44cd4fe9a7c450cf0e3e0fe955d43f824bb3ebe / 37398-37469
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/a44cd4fe9a7c450cf0e3e0fe955d43f824bb3ebe","sourcedb":"CORD-19","sourceid":"a44cd4fe9a7c450cf0e3e0fe955d43f824bb3ebe","text":"Control treatment consisted of IP administration of 100 μl sterile PBS.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T224","span":{"begin":0,"end":71},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T224","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T224","span":{"begin":0,"end":71},"obj":"Sentence"}],"attributes":[{"subj":"T224","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T104","span":{"begin":59,"end":66},"obj":"Disease"},{"id":"T58671","span":{"begin":59,"end":66},"obj":"Disease"}],"attributes":[{"id":"A104","pred":"mondo_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/MONDO_0005047"},{"id":"A23292","pred":"mondo_id","subj":"T58671","obj":"http://purl.obolibrary.org/obo/MONDO_0005047"},{"subj":"T104","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T58671","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ebec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#d293ec"},{"id":"CORD-19-PD-MONDO","color":"#93ecb8"}]}]}}